Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	9 Months Ended
	Jul. 31, 2011	Aug. 01, 2010
Cash flows from operating activities:
Net loss	$ (13,361)	$ (21,441)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	25,249	26,017
Share-based compensation expense	5,132	3,578
Refinancing costs		174
Gain on embedded derivative	(19)	(930)
Loss on sale of property, plant and equipment	41	166
Provision for doubtful accounts	1,452	131
Benefit from deferred income taxes	(6,227)	(580)
Asset impairments, net	(93)	849
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	(11,440)	924
Inventories	(34,938)	(33,774)
Income tax receivable	14,209	15,016
Prepaid expenses and other	(57)	1,424
Accounts payable	21,250	649
Accrued expenses	3,966	(13,868)
Other, net	283	920
Net cash provided by (used in) operating activities	5,447	(20,745)
Cash flows from investing activities:
Capital expenditures	(14,735)	(11,258)
Proceeds from sale of property, plant and equipment	582	760
Net cash used in investing activities	(14,153)	(10,498)
Cash flows from financing activities:
Decrease (increase) of restricted cash	(4)	10,141
Proceeds from ABL Facility	43	241
Payments on ABL Facility	(43)	(246)
Payments on term loan	(5,250)	(13,695)
Payment of convertible notes		(59)
Payments on other long-term debt		(190)
Payments on note payable	(1,105)	(1,289)
Payment of financing costs	(100)	(50)
Payment of cash dividends on Convertible Preferred Stock	(11,039)
Purchase of treasury stock	(1,477)	(381)
Net cash (used in) financing activities	(18,975)	(5,528)
Effect of exchange rate changes on cash and cash equivalents	(63)	(5)
Net decrease in cash and cash equivalents	(27,744)	(36,776)
Cash and cash equivalents at beginning of period	77,419	90,419
Cash and cash equivalents at end of period	$ 49,675	$ 53,643